Want to see JP:7071 full AI Analyst Report?
Top Page
Amvis Holdings.Inc.
(7071)
Select Model
Select Model
Rating:64Neutral
Price Target:
¥453.00
▼(-4.43% Downside)
Action:Reiterated
Date:08/19/26
The score is primarily held back by weakening profitability and negative/worsening free cash flow, despite continued revenue growth. Technicals are supportive with an ongoing uptrend, though indicators suggest near-overbought conditions. Valuation is reasonable on earnings (P/E 13.76) but offers limited yield support (~0.95%).
Positive Factors
Consistent Revenue Growth
Continued revenue expansion indicates sustained demand for Amvis’s nursing and caregiving services. Growth in the operating base can support longer-term scale, although future conversion into profit depends on staffing costs and reimbursement economics.
Negative Factors
Sharp Margin Compression
Material deterioration in gross and net margins shows that revenue growth is not translating efficiently into earnings. If cost pressures persist, weaker profitability could limit reinvestment capacity and reduce the benefit of further operational expansion.
Read all positive and negative factors
Positive Factors
Negative Factors
Consistent Revenue Growth
Continued revenue expansion indicates sustained demand for Amvis’s nursing and caregiving services. Growth in the operating base can support longer-term scale, although future conversion into profit depends on staffing costs and reimbursement economics.
Read all positive factors
Amvis Holdings.Inc. (7071) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥41.00B
Dividend Yield0.96%
Average Volume (3M)1.46M
Price to Earnings (P/E)12.6
Beta (1Y)1.28
Revenue Growth6.17%
EPS Growth-33.01%
CountryJP
Employees5,135
SectorGeneral
Sector StrengthN/A
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)26.19
Shares Outstanding98,313,600
10 Day Avg. Volume829,320
30 Day Avg. Volume1,455,976
Financial Highlights & Ratios
PEG Ratio-0.32
Price to Book (P/B)1.63
Price to Sales (P/S)1.19
P/FCF Ratio-13.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥387.50Price Target Upside-18.25% Downside
Rating ConsensusHold
Number of Analyst Covering2
EPS Forecast (FY)25
Revenue Forecast (FY)¥50.63B
Amvis Holdings.Inc. Business Overview & Revenue Model
Company Description
Amvis Holdings, Inc. is a Japanese firm that delivers a wide array of care services. These offerings encompass residential nursing facilities, at-home nursing and general care, as well as various support programs for individuals with disabilities....
How the Company Makes Money
The company makes money primarily by earning service revenue from the provision of nursing care and related support services delivered through its operating subsidiaries. Revenue is generated when care is delivered to eligible users, with payments...
Amvis Holdings.Inc. Financial Statement Overview
Summary
Income Statement
65
Positive
Balance Sheet
70
Positive
Cash Flow
55
Neutral
| Breakdown | TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 38.41B | 49.17B | 42.48B | 31.98B | 23.07B | 15.33B |
| Gross Profit | 10.62B | 14.79B | 17.05B | 13.26B | 9.67B | 6.29B |
| EBITDA | 7.08B | 9.02B | 12.76B | 10.39B | 7.12B | 4.49B |
| Net Income | 2.56B | 3.66B | 7.44B | 6.31B | 4.28B | 2.63B |
Balance Sheet | ||||||
| Total Assets | 83.92B | 84.16B | 71.99B | 55.69B | 41.85B | 31.99B |
| Cash, Cash Equivalents and Short-Term Investments | 9.21B | 10.83B | 8.87B | 12.13B | 11.34B | 11.19B |
| Total Debt | 38.37B | 40.15B | 31.75B | 23.05B | 17.43B | 12.75B |
| Total Liabilities | 45.98B | 48.02B | 38.77B | 29.17B | 21.39B | 15.65B |
| Stockholders Equity | 37.94B | 36.13B | 33.21B | 26.52B | 20.46B | 16.34B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -4.38B | -8.50B | -3.04B | -2.70B | -2.78B |
| Operating Cash Flow | 0.00 | 6.03B | 7.48B | 6.80B | 4.42B | 2.58B |
| Investing Cash Flow | 0.00 | -10.43B | -16.83B | -10.31B | -7.75B | -5.78B |
| Financing Cash Flow | 0.00 | 6.37B | 6.08B | 4.30B | 3.49B | 11.05B |
Amvis Holdings.Inc. Technical Analysis
Positive
474.00
Price Trends
377.80
Positive
378.95
Positive
424.12
Negative
Market Momentum
11.91
Positive
59.20
Neutral
41.22
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7071, the sentiment is Positive. The current price of 474 is above the 20-day moving average (MA) of 405.55, above the 50-day MA of 377.80, and above the 200-day MA of 424.12, indicating a neutral trend. The MACD of 11.91 indicates Positive momentum. The RSI at 59.20 is Neutral, neither overbought nor oversold. The STOCH value of 41.22 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7071.
Amvis Holdings.Inc. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥45.59B | 14.45 | 21.08% | 1.94% | 12.86% | 30.95% | |
70 Outperform | ¥45.78B | 11.34 | ― | 2.63% | 5.16% | 37.79% | |
64 Neutral | ¥41.00B | 12.61 | ― | 0.91% | 6.17% | -33.01% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
46 Neutral | ¥4.07B | 12.24 | ― | 1.41% | 14.91% | -39.00% |
* General Sector Average
JP:7071
Amvis Holdings.Inc.
416.00
-196.94
-32.13%
JP:6099
Elan Corp.
750.00
-50.48
-6.31%
JP:6062
Charm Care Corporation
1,404.00
385.08
37.79%
JP:7061
Japan Hospice Holdings Inc.
475.00
-819.64
-63.31%
Amvis Holdings.Inc. Corporate Events
Amvis Holdings Posts Revenue Growth but Forecasts Profit Decline While Keeping Dividend Steady
Aug 14, 2026
Amvis Holdings, Inc. reported consolidated net sales of ¥38.29 billion for the first nine months of the fiscal year ending September 30, 2026, up 5.3% year on year, while EBITDA declined 8.1% and profit attributable to owners of the parent fe...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.